期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Comment on“Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”

Comment on “Predictors of short-term outcomes related to central subfield foveal thickness after intravitreal bevacizumab for macular edema due to central retinal vein occlusion”
下载PDF
导出
摘要 Dear Editor,We read with great interest the article by Wang et al which investigated the predictive factors for short-term outcomes related to central subfield foveal thickness （CSFT） after intravitreal bevacizumab （IVB; Avastin, Genentech Inc., South Francisco, CA, USA） injections in 60 patients with macular edema （ME） secondary to central retinal vein occlusion （CRVO）. The authors concluded that IVB significantly improved visual acuity and CSFT after 3mo. Dear Editor,We read with great interest the article by Wang et al which investigated the predictive factors for short-term outcomes related to central subfield foveal thickness （CSFT） after intravitreal bevacizumab （IVB; Avastin, Genentech Inc., South Francisco, CA, USA） injections in 60 patients with macular edema （ME） secondary to central retinal vein occlusion （CRVO）. The authors concluded that IVB significantly improved visual acuity and CSFT after 3mo.
作者 Dan Calugaru Mihai Calugaru
机构地区 Department of Ophthalmology
出处 《International Journal of Ophthalmology(English edition)》 SCIE CAS 2017年第9期1481-1482,共2页 国际眼科杂志（英文版）
分类号 R77 [医药卫生—眼科]
  • 相关文献

参考文献1

二级参考文献40

  • 1Rogers S, Mcintosh RL, Cheung N, Lim L, Wang JJ, Mitchell P, Kowalski JW, Nguyen H, Wong TY, International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. OphtDaimology 2010; 117(2):313-319 e311.
  • 2Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. 7)aZ; Am OphtDaimol S>e 2000;98: 133-141; discussion 141-143.
  • 3Bertelsen M, Linneberg A, Christoffersen N, Vorum H, Gade E, Larsen M. Mortality in patients with central retinal vein occlusion. OphlhaimolooY 2014;121(3):637-642.
  • 4Glacet-Bemard A, Mahdavi KN, Coscas G, Zourdani A, Fardeau C. Macular grid photocoagulation in persistent macular edema due to central retinal vein occlusion. lif.l OpiltDaimol 1994;4(3): 166-174.
  • 5Jonas JB, Akkoyun I, Kamppeter B, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonirle for treatment of central retinal vein occlusion. IN .I OphtDalnoi2005;15(6):751-758.
  • 6Berker N, Batman C. Surgical treatment of central retinal vein occlusion. Acl<l 0phlhJimol 2008;86(3):245 -252.
  • 7Costa RA, Jorge R, Calucci D, Melo LA, Cardillo JA, Scott IU. Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 2007;27(2):141-149.
  • 8Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am.lOphlhilOno2007;144(6):864-871.
  • 9Priglinger SG, Wolf AH, Kreutzer TC, Kook D, Hofer A, Strauss RW, Alge CS, Kunze C, Haritoglou C, Kampik A. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial. Heb:IJa 2007;27(8): 1004-10 12.
  • 10Jaissle GB, Ziemssen F, Petermeier K, Szurman P, Ladewig M, Gelisken F, Volker M, Holz FG, Bartz-Schmidt KU. Bevacizumab for treatment of macular edema secondary to retinal vein occlusion. OphtDaimologe 2006; 103(6):471-475.

共引文献2

International Journal of Ophthalmology(English edition)
2017年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部